ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 745,94
-0,23%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Belite Bio Inc (BLTE)

  7. Belite Bio Inc (BLTE) Actualités

BLTE Belite Bio Inc

43,20
2,10 (5,11%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Belite Bio Inc BLTE NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
2,10 5,11% 43,20 06:00:09
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
41,05 40,88 43,45 43,20 41,10
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202422:15GLOBEBelite Bio Announces Presentation at the Association for..
26/4/202401:15GLOBEBelite Bio Announces $25 Million Registered Direct Offering
22/3/202413:00GLOBEBelite Bio Announces PMDA Submission of Tinlarebant for..
12/3/202403:28GLOBEBelite Bio Announces Availability of Annual Report on Form..
12/3/202402:27GLOBEBelite Bio Reports Fourth Quarter and Full Year 2023..
06/3/202414:00GLOBEBelite Bio to Host Webcast on March 12, 2024, to Discuss..
04/3/202414:00GLOBEBelite Bio to Participate in the Leerink Partners Global..
13/2/202403:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202402:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202414:00GLOBEBelite Bio to Present at the Oppenheimer 34th Annual..
28/12/202322:16EDGAR2Form 144 - Report of proposed sale of securities
28/12/202322:15EDGAR2Form 144 - Report of proposed sale of securities
30/11/202314:00GLOBEBelite Bio to Participate in the Benchmark Company’s..
28/11/202323:16EDGAR2Form 144 - Report of proposed sale of securities
20/11/202314:00GLOBEBelite Bio to Participate in the BTIG Ophthalmology Day
16/11/202322:41EDGAR2Form 144 - Report of proposed sale of securities
16/11/202322:36EDGAR2Form 144 - Report of proposed sale of securities
14/11/202302:15GLOBEBelite Bio Reports Third Quarter 2023 Operational Highlights..
10/11/202314:35GLOBEDeutsche Bank ADR Investor Conference: Presentations Now..
07/11/202314:00GLOBEBelite Bio to Host Webcast on November 14, 2023, to Discuss..
06/11/202322:00GLOBEBelite Bio, Inc. to present at the Deutsche Bank ADR Virtual..
06/11/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202314:00GLOBEBelite Bio Presents Results from a 24-month, Phase 2 Study..
01/11/202313:35GLOBEInternational companies to host live webcasts at Deutsche..
27/10/202314:00GLOBEBelite Bio Announces Presentation at the American Academy of..
19/9/202318:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/8/202323:16EDGAR2Form 144 - Report of proposed sale of securities
31/8/202322:48EDGAR2Form 144 - Report of proposed sale of securities
09/8/202312:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202312:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NASDAQ
BLTE
Belite Bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés